190,000 Shares in Surrozen, Inc. (NASDAQ:SRZN) Purchased by Armistice Capital LLC

Armistice Capital LLC purchased a new stake in Surrozen, Inc. (NASDAQ:SRZN) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 190,000 shares of the company’s stock, valued at approximately $2,080,000. Armistice Capital LLC owned 5.94% of Surrozen at the end of the most recent quarter.

Surrozen Stock Up 1.3 %

Shares of NASDAQ SRZN opened at $10.33 on Friday. The firm’s 50 day simple moving average is $8.49 and its 200-day simple moving average is $10.02. Surrozen, Inc. has a 12 month low of $4.50 and a 12 month high of $16.19.

Surrozen (NASDAQ:SRZN) last released its quarterly earnings results on Monday, August 12th. The company reported ($1.54) EPS for the quarter, beating the consensus estimate of ($2.79) by $1.25. Equities analysts predict that Surrozen, Inc. will post -9.49 EPS for the current fiscal year.

Surrozen Profile

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.